Ngā hua rapu - Annette Langer‐Gould
- E whakaatu ana i te 1 - 20 hua o te 34
- Haere ki te Whārangi Whai Ake
-
1
Validation of the Swedish Multiple Sclerosis Register mā Peter Alping, Fredrik Piehl, Annette Langer‐Gould, Thomas Frisell
I whakaputaina 2018Artigo -
2
Multiple sclerosis, rituximab, and COVID‐19 mā Annette Langer‐Gould, Jessica B. Smith, Bonnie H. Li
I whakaputaina 2021Artigo -
3
-
4
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections mā Annette Langer‐Gould, Bonnie H. Li, Jessica Smith, Stanley Xu
I whakaputaina 2024Artigo -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Rituximab, MS, and pregnancy mā Jessica B. Smith, Kerstin Hellwig, Katharina Fink, Deirdre J. Lyell, Fredrik Piehl, Annette Langer‐Gould
I whakaputaina 2020Artigo -
14
-
15
-
16
-
17
-
18
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder mā Andrea I. Ciplea, Annette Langer‐Gould, Annick de Vries, Tiny Schaap, Sandra Thiel, Marius Ringelstein, Ralf Gold, Kerstin Hellwig
I whakaputaina 2020Artigo -
19
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses mā Kerstin Hellwig, Milena Rockhoff, Sandra Herbstritt, Nadja Borisow, Aiden Haghikia, Birte Elias-Hamp, Sylvia Menck, Ralf Gold, Annette Langer‐Gould
I whakaputaina 2015Artigo -
20
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy mā Kerstin Hellwig, Marianne Tokic, Sandra Thiel, Nina Esters, Charlotte Spicher, Nina Timmesfeld, Andrea I. Ciplea, Ralf Gold, Annette Langer‐Gould
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Multiple sclerosis
Immunology
Biology
Cohort
Environmental health
Pediatrics
Population
Disease
Genetics
Sociology
Confidence interval
Demography
Obstetrics
Pregnancy
Psychiatry
Retrospective cohort study
Cohort study
Rituximab
Anthropology
Ethnic group
Natalizumab
Physics
Breastfeeding
Incidence (geometry)
Lymphoma
Odds ratio
Optics
Pathology